[1]
Pang, N.C. and Adam S Hassan 2024. The use of tocilizumab to treat recurrent thyroid eye disease previously treated with teprotumumab. Digital Journal of Case Reports in Ophthalmology. 4, (Aug. 2024). DOI:https://doi.org/10.62856/djcro.v1i1.26.